← FDA Drug Approvals (Drugs@FDA)

AMIKACIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2016-05-12

Drug application

FDA Application #

ANDA203323

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMIKACIN SULFATE

Generic name

AMIKACIN SULFATE

Active ingredients

AMIKACIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2016-05-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown